Kezar Life Sciences, Inc.
KZRDelisted May 11, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645666
Kezar Life Sciences, Inc. was delisted on May 11, 2026; its insiders filed their last Form 4 on May 11, 2026; 43 institutions reported holding it in 13F filings for Q1 2026, worth $32.8M in total; no superinvestor held it.
13F holders, Q2 2024
Institutional positions in Kezar Life Sciences, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 81
- −3 vs. Q1 2024
- Shares held
- 39.4M
- −5.37M (−12.0%) vs. Q1 2024
- Total value
- $23.6M
- −$16.7M (−41.4%) vs. Q1 2024
- New holders
- 23
- 17 more added
- Sold out
- 26
- 26 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KZR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 43 | $32.8M |
| Q4 2025 | 43 | $28.1M |
| Q3 2025 | 39 | $16.5M |
| Q2 2025 | 40 | $20.5M |
| Q1 2025 | 41 | $21.1M |
| Q4 2024 | 43 | $28.2M |
| Q3 2024 | 60 | $31.6M |
| Q2 2024 | 81 | $23.6M |
| Q1 2024 | 85 | $40.3M |
| Q4 2023 | 81 | $46.8M |
| Q3 2023 | 82 | $66.0M |
| Q2 2023 | 104 | $139.4M |
| Q1 2023 | 137 | $188.1M |
| Q4 2022 | 123 | $404.2M |
| Q3 2022 | 132 | $495.5M |
| Q2 2022 | 127 | $454.0M |
| Q1 2022 | 123 | $734.1M |
| Q4 2021 | 107 | $674.1M |
| Q3 2021 | 77 | $242.7M |
| Q2 2021 | 75 | $150.1M |
| Q1 2021 | 83 | $158.0M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Kezar Life Sciences, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| First Bank & Trust | 0 | $0 | 0.00% | −11,739−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −6,814−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −4,127−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −1,629−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| Mirae Asset Global Investments Co., Ltd. | 0 | $0 | 0.00% | −26,195−100.0% | Sold out |
| Cutler Group LP | – | – | – | – | Not filed |